Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 125,308 shares at $2.46 ($305K) on 2022-06-14, disclosed to the SEC on 2022-06-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 7,596 | $16K | 5.2% |
| 2 | $2.46 | 58,856 | $145K | 47.4% |
| 3 | $2.46 | 58,856 | $145K | 47.4% |
| Total | $2.44 avg | 125,308 | $305K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |